Emerging incretin and multi agonist based treatments the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio kidney liver metabolic diseases and beyond Metabolism Clinical and Experimental Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First in Class Twincretin Diabetes Therapy Springer Nature Link Mazdutide vs Tirzepatide: A Comparative Analysis for Weight Loss Exploring Peptides Diabetes Mellitus, Type 2 Competitive Landscape Mazdutide vs Tirzepatide vs Semaglutide: Comparative Efficacy Ney Carter Borges MD M.Sc. Ph.D FESC,FACC,FAHA,FACP. posted on the topic LinkedIn